| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A comparison of adherence, outcomes, and costs among opioid use disorder Medicaid patients treated with buprenorphine and methadone: A view from the payer perspective
|
Kinsky, Suzanne
|
|
2019
|
104 |
C |
p. 15-21
|
article
|
| 2 |
A comparison of buprenorphine and psychosocial treatment outcomes in psychosocial and medical settings
|
Presnall, Ned J.
|
|
2019
|
104 |
C |
p. 135-143
|
article
|
| 3 |
A randomized pilot trial of two parenting interventions for fathers in residential substance use disorder treatment
|
Stover, Carla Smith
|
|
2019
|
104 |
C |
p. 116-127
|
article
|
| 4 |
A systematic review of reinforcement-based interventions for substance use: Efficacy, mechanisms of action, and moderators of treatment effects
|
Fazzino, Tera L.
|
|
2019
|
104 |
C |
p. 83-96
|
article
|
| 5 |
Brief video intervention to improve attitudes throughout medications for opioid use disorder in a correctional setting
|
Lam, Jeffrey A.
|
|
2019
|
104 |
C |
p. 28-33
|
article
|
| 6 |
Buprenorphine in the United States: Motives for abuse, misuse, and diversion
|
Chilcoat, Howard D.
|
|
2019
|
104 |
C |
p. 148-157
|
article
|
| 7 |
C2: editorial board
|
|
|
2019
|
104 |
C |
p. IFC
|
article
|
| 8 |
Court personnel attitudes towards medication-assisted treatment: A state-wide survey
|
Andraka-Christou, Barbara
|
|
2019
|
104 |
C |
p. 72-82
|
article
|
| 9 |
Effects of ascending buprenorphine doses on measures of experimental pain: A pilot study
|
Nielsen, S.
|
|
2019
|
104 |
C |
p. 128-134
|
article
|
| 10 |
Insomnia severity during early abstinence is related to substance use treatment completion in adults enrolled in an intensive outpatient program
|
Wilkerson, Allison K.
|
|
2019
|
104 |
C |
p. 97-103
|
article
|
| 11 |
Medication-assisted treatment for opioid use disorder within a 12-step based treatment center: Feasibility and initial results
|
Klein, Audrey A.
|
|
2019
|
104 |
C |
p. 51-63
|
article
|
| 12 |
Medication-enhanced behavior therapy for alcohol use disorder: Naltrexone, Alcoholics Anonymous Facilitation, and OPRM1 genetic variation
|
Stewart, Scott H.
|
|
2019
|
104 |
C |
p. 7-14
|
article
|
| 13 |
Nowhere to go? Examining facility acceptance levels for serving individuals using medications for opioid used disorder
|
Kepple, Nancy J.
|
|
2019
|
104 |
C |
p. 42-50
|
article
|
| 14 |
Opioid users' willingness to receive prolonged-release buprenorphine depot injections for opioid use disorder
|
Tompkins, Charlotte N.E.
|
|
2019
|
104 |
C |
p. 64-71
|
article
|
| 15 |
Perceptions about fentanyl-adulterated heroin and overdose risk reduction behaviors among persons seeking treatment for heroin use
|
Stein, Michael D.
|
|
2019
|
104 |
C |
p. 144-147
|
article
|
| 16 |
Provider-directed marketing may increase prescribing of medications for opioid use disorder
|
Nguyen, Thuy
|
|
2019
|
104 |
C |
p. 104-115
|
article
|
| 17 |
Smokers with opioid use disorder may have worse drug use outcomes after varenicline than nicotine replacement
|
Martin, Rosemarie A.
|
|
2019
|
104 |
C |
p. 22-27
|
article
|
| 18 |
TOC (update)
|
|
|
2019
|
104 |
C |
p. iii-iv
|
article
|
| 19 |
Treating opioid dependence with extended-release naltrexone (XR-NTX) in Ukraine: Feasibility and three-month outcomes
|
Makarenko, Iuliia
|
|
2019
|
104 |
C |
p. 34-41
|
article
|
| 20 |
Willingness to use and pay for smoking cessation service via text-messaging among Vietnamese adult smokers, 2017
|
Ngan, Tran Thu
|
|
2019
|
104 |
C |
p. 1-6
|
article
|
Journal description